IDH2 and glioblastoma: Although we studied only GBM cases, our results showed that IDH1/IDH2 mutations were more powerful prognostic factors than primary/secondary GBM classification; we observed better OS in primary GBM with mutated IDH1/IDH2 compared to the secondary GBM with no mutation (Figure 2(a)).